Certificate of Analysis
Third Party Tested
Molecular Profile
Compound
SS-31
Batch #
N/A
Formula
C32H49N9O5
Mol Wt
639.8 g/mol
CAS
736992-21-5
Latest
ISO 17025
8× Testing
99.35%
Purity
VariantSS-31
COA ##12726
Labeled10mg
Validation KeyAXISBIOTECH
Tested04/03/26
Full QC Panel - 8× tested
✓
Purity (HPLC) - 99.35%
✓
Net Peptide Content - 10mg
✓
Identity (HPLC) - SS-31
✓
Fentanyl Screen - Not Detected
✓
HPLC Conformity mean - >99%
✓
ISO/IEC 17025 Accredited
Storage Requirements
Stability Information
Lyophilized (powder)
−20°C long-term
2–8°C
Reconstituted
Recommended condition
Light protection
Store away from light
Sealed lyophilized vials are heat-stable; refrigerating or freezing sealed vials is optional. 2–8°C applies to reconstituted solutions.
Peer-Reviewed Literature
Research & References
Research and reference material related to this compound.
01
Elamipretide (SS-31) in heart failure with reduced ejection fraction: the PROGRESS-HF trial
02
SS-31 reduces superoxide production in failing myocardium
03
A novel cell-permeable antioxidant peptide SS-31 targets mitochondria to protect against cell death
04
Mitochondria-targeted peptide SS-31 improves mitochondrial bioenergetics in muscle
05
SS-31 restores mitochondrial function and reverses aging phenotypes in senescent cells
Safety & Regulatory Compliance Warning
These products are intended solely for laboratory research and analytical applications. They have not been evaluated by the U.S. Food and Drug Administration (FDA) and are not approved for therapeutic use, diagnosis, treatment, or prevention of disease. Under no circumstances should these materials be used for human or animal consumption.
